| Tamiko Jackson, | |
|
920 Doug White Dr Ste 510, Myrtle Beach, SC 29572-4183 | |
| (843) 497-7772 | |
| (843) 848-7530 |
| Full Name | Tamiko Jackson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 920 Doug White Dr Ste 510, Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063875474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 20057 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grand Strand Regional Medical Center | Myrtle beach, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grand Strand Surgical Specialists Llc | 4082770656 | 52 |
News Archive
Biotage announced on 22 January 2009 that the company had decided to move the manufacturing of its products from its factory in Charlottesville, Virginia, to contract manufacturers and Biotage's manufacturing plant in Cardiff, Wales. The transfer of this business has now successfully been finalized.
American Pharmaceutical Partners announced today that February 8, 2005 is the launch date of Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Abraxane will be marketed by the national sales force of Abraxis Oncology, APP's proprietary sales and marketing division.
Studies screening the genome of hundreds of thousands of individuals (known as Genome-wide association studies or GWAS) have linked more than 100 regions in the genome to the risk of developing cardiovascular disease.
Despite policy pressure on GPs to offer consultations by email or internet video programmes such as Skype, few GPs do and most have no plans to introduce them in future, according to a new study.
› Verified 9 days ago
| Entity Name | Grand Strand Surgical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841465804 PECOS PAC ID: 4082770656 Enrollment ID: O20090305000535 |
News Archive
Biotage announced on 22 January 2009 that the company had decided to move the manufacturing of its products from its factory in Charlottesville, Virginia, to contract manufacturers and Biotage's manufacturing plant in Cardiff, Wales. The transfer of this business has now successfully been finalized.
American Pharmaceutical Partners announced today that February 8, 2005 is the launch date of Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Abraxane will be marketed by the national sales force of Abraxis Oncology, APP's proprietary sales and marketing division.
Studies screening the genome of hundreds of thousands of individuals (known as Genome-wide association studies or GWAS) have linked more than 100 regions in the genome to the risk of developing cardiovascular disease.
Despite policy pressure on GPs to offer consultations by email or internet video programmes such as Skype, few GPs do and most have no plans to introduce them in future, according to a new study.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tamiko Jackson, 920 Doug White Dr Ste 510, Myrtle Beach, SC 29572-4183 Ph: (843) 497-7772 | Tamiko Jackson, 920 Doug White Dr Ste 510, Myrtle Beach, SC 29572-4183 Ph: (843) 497-7772 |
News Archive
Biotage announced on 22 January 2009 that the company had decided to move the manufacturing of its products from its factory in Charlottesville, Virginia, to contract manufacturers and Biotage's manufacturing plant in Cardiff, Wales. The transfer of this business has now successfully been finalized.
American Pharmaceutical Partners announced today that February 8, 2005 is the launch date of Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Abraxane will be marketed by the national sales force of Abraxis Oncology, APP's proprietary sales and marketing division.
Studies screening the genome of hundreds of thousands of individuals (known as Genome-wide association studies or GWAS) have linked more than 100 regions in the genome to the risk of developing cardiovascular disease.
Despite policy pressure on GPs to offer consultations by email or internet video programmes such as Skype, few GPs do and most have no plans to introduce them in future, according to a new study.
› Verified 9 days ago
Wilma J Spencer, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 7724 N Kings Hwy, Myrtle Beach, SC 29572 Phone: 843-663-1013 Fax: 843-663-1017 | |
Mrs. Cyril Eunice Aboy Ferreras, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1303 38th Ave N, Myrtle Beach, SC 29577 Phone: 843-445-1697 | |
Mary Taylor Jackson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8121 Rourk St, Myrtle Beach, SC 29572 Phone: 843-692-5000 Fax: 843-692-5010 | |
Mrs. Angela Kathline Naples, APRN FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-692-1000 | |
Mary E Byrd, DNP, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5010 Carolina Forest Blvd, Myrtle Beach, SC 29579 Phone: 843-236-2700 Fax: 843-236-2726 | |
Alexander Petkovsek, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 920 Doug White Dr Ste 210, Myrtle Beach, SC 29572 Phone: 843-497-6348 Fax: 843-497-6351 | |
Mrs. June Jones, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3381 Phillis Blvd, Myrtle Beach, SC 29577 Phone: 843-477-0177 |